If you’ve just been handed a “stage 4” diagnosis and typed stage 4 endometriosis life expectancy into a search bar at two in the morning, here is the thing you need to read first: endometriosis is not cancer, and it is not a terminal illness. Women with severe endometriosis grow old. They retire, they meet grandchildren, they die of the same things everyone else dies of, decades later.
The word “stage” is doing a lot of damage here, and it’s worth explaining exactly why.
Stage 4 measures territory, not danger
The staging system most surgeons use is the revised American Society for Reproductive Medicine score, built in 1996. During surgery, a doctor assigns points for how many lesions there are, how deep they sit, how big any ovarian cysts are, and how much scar tissue has glued organs to one another. Add up the points. Forty or more puts you in stage IV.
That’s the whole system. It’s a map of how much real estate the disease occupies, borrowed from oncology’s vocabulary but describing nothing about survival.
This creates a genuinely strange situation that specialists have complained about for years. A woman with minimal stage 1 disease can be bedbound three days a month, while someone with stage 4 might discover it incidentally during an unrelated operation. Critical reviews of the rASRM system have repeatedly found poor correlation between stage and pain severity, and even poor correlation with how difficult the surgery turns out to be. The score also underrepresents deep infiltrating endometriosis, which is often the variety that causes the worst symptoms, and that’s why many surgeons default to calling any deep disease “stage 4” regardless of the arithmetic.
So the number tells your surgeon roughly what they’re walking into. It does not tell you how long you’ll live.
What research says about stage 4 endometriosis life expectancy
There is no published figure. No cohort study has ever tracked women by rASRM stage and reported a survival number, because nobody expects stage to predict death. What researchers have studied is whether endometriosis in general shifts long-term mortality, and the findings are mixed enough that honesty requires laying both sides out.
A large 2024 analysis from the Nurses’ Health Study II, published in The BMJ, followed more than 110,000 women for nearly three decades and found a 31% higher relative risk of death before age 70 among those with surgically confirmed endometriosis. That headline sounds alarming until you look at the absolute numbers underneath it: roughly 2.0 deaths per 1,000 person-years versus 1.4 in women without the condition. A difference of six-tenths of a death per thousand women per year is real, but it is not the picture the phrase “31% higher” conjures.
A nationwide Danish study of 60,508 women published in the European Heart Journal found increased rates of heart attack and stroke over a median 16 years of follow-up, yet found no increase in all-cause death. And a 2026 systematic review and meta-analysis pooling the available evidence concluded there was no statistically significant association between endometriosis and all-cause mortality at all.
Three serious pieces of research, three different answers. What that tells you is that if any effect exists, it’s small enough to appear and disappear depending on how you slice the data. Nothing in that literature supports the idea that a stage 4 diagnosis assigns you a shortened timeline.
Complications that do deserve your attention
Dismissing the mortality question doesn’t mean severe endometriosis is harmless. It means the real risks are specific, mostly preventable, and worth knowing by name.
Silent kidney damage. This is the one most people have never heard of and the one that matters most. When deep lesions wrap around a ureter, the tube can narrow and back urine up into the kidney. The cruel part is that it frequently causes no symptoms at all. Case series document women losing an entire kidney before anyone realised anything was wrong, with some reports estimating that a substantial share of ureteral endometriosis cases involve silent renal loss. Ureteral involvement is uncommon, affecting well under 1% of endometriosis patients overall, but it is concentrated in exactly the deep, severe disease that earns a stage 4 label. Ask whether your kidneys have been imaged. If the answer is no, ask again.
Bowel obstruction. Nodules on the rectum or sigmoid colon can narrow the bowel. Complete obstruction is rare and usually builds gradually rather than striking out of nowhere, but it is a surgical emergency when it happens.
Ovarian cancer risk, in proportion. Endometriosis roughly doubles the relative risk of certain ovarian cancers, specifically the clear cell and endometrioid subtypes, with the highest estimates in women who have endometriomas or deep disease. But pooled analyses put the absolute lifetime risk at around 1.9%, against roughly 1.3% in the general population. Put differently, about 98 out of 100 women with endometriosis will never develop ovarian cancer. Current evidence does not support routine cancer screening or preventive surgery on the basis of an endometriosis diagnosis alone. When these cancers do occur in women with endometriosis, they tend to be diagnosed younger and at earlier stages, with better survival than ovarian cancers that aren’t linked to the condition.
Cardiovascular health. The chronic inflammation that drives endometriosis appears to nudge heart risk upward over decades. This is one of the few genuinely actionable long-term findings, because cardiovascular risk responds to things you can actually influence.
Early surgical menopause. If ovaries are removed before around 45 and hormone replacement isn’t started, the long-term cardiovascular and bone consequences are well documented and not trivial. This is worth flagging because “stage 4” sometimes prompts aggressive surgical recommendations, and removing ovaries does not cure endometriosis lesions sitting elsewhere in the pelvis.
What genuinely changes outcomes
The factors that shape stage 4 endometriosis life expectancy and, more importantly, quality of life have almost nothing to do with the stage number and almost everything to do with the care you get.
Find a genuine excision specialist. There is a meaningful difference between a general gynaecologist who ablates surface lesions and a surgeon who excises deep disease, often working alongside a colorectal surgeon or urologist. Recurrence rates and symptom outcomes differ substantially. Accredited endometriosis centres exist in most countries; the ESHRE guideline is a reasonable document to read before your consultation so you know what best practice looks like.
Insist on kidney imaging. A renal ultrasound is cheap, quick, and the single highest-value test in severe disease. It should be part of routine follow-up for anyone with deep infiltrating endometriosis.
Push back on reflexive hysterectomy. It may be the right answer. It also may not be, particularly if lesions sit on the bowel or peritoneum rather than the uterus. Ask specifically what problem the operation is expected to solve.
Discuss HRT if your ovaries come out young. This conversation is frequently skipped and shouldn’t be.
Treat the pain as a condition in its own right. Long-standing pelvic pain rewires the nervous system, and pelvic floor physiotherapy, pain specialists, and psychological support aren’t consolation prizes for when surgery fails. They’re part of the treatment. The mental health toll of years of dismissal is real, and getting support for it is not a sign you’ve stopped fighting the physical disease.
Signs that need same-day attention
Call your doctor or go to emergency care for: inability to pass urine or stool alongside a distended, painful abdomen; persistent vomiting with abdominal pain; severe one-sided flank pain; sudden severe pelvic pain with faintness; or chest pain and breathlessness that recurs around your period, which can rarely signal endometriosis affecting the diaphragm or lungs.
Common questions
Question
Answer
Does stage 4 endometriosis life expectancy differ from the general population?
No published research assigns a different life expectancy specifically to stage 4 disease. Studies on endometriosis and mortality have mixed findings, and any reported effect appears small in absolute terms.
Will it keep progressing to a “stage 5”?
There is no official stage 5. Some surgeons may use the term informally for extremely extensive disease. Endometriosis can progress in some people and remain stable in others. Stage 4 is not a countdown.
Can endometriosis turn into cancer?
Malignant transformation is rare, and the absolute cancer risk remains low. An endometriosis diagnosis alone is not generally a reason to remove healthy organs preventively.
Does menopause end it?
Symptoms often improve after menopause, but existing adhesions and scar tissue do not simply disappear. Some women continue experiencing pain afterwards.
Bottom line
The honest answer on stage 4 endometriosis life expectancy is that the question is aimed at the wrong target. The staging system was designed to describe surgical findings and predict fertility, not survival. What severe endometriosis genuinely threatens is your organ function, your fertility, your working life, and your capacity to get through an ordinary week without pain deciding your schedule. Those are the things worth fighting for, and they respond to good surgical care, informed advocacy, and refusing to let a number on a report do your thinking for you.
This article is for general information and does not replace individual medical advice. Endometriosis presents differently in every person, and decisions about surgery, hormone treatment, or fertility should be made with a clinician who knows your history and imaging.
About Dr. Mary E. D Alton (Gynecologist)
Dr. Mary E. D'Alton is a globally recognized, board-certified obstetrician-gynecologist specializing in maternal-fetal medicine (MFM). She is a premier authority on high-risk pregnancies, complex maternal medical conditions, and advanced prenatal diagnostics.